The main symptom of an acute exacerbation of interstitial pulmonary fibrosis is rapid progression of dyspnea or the development of respiratory distress. The time from onset to treatment is 2-30 days, and there may be a dry cough and fever. Acute exacerbations of interstitial pulmonary fibrosis can occur at any point in the course of the disease. The risk of acute exacerbation does not appear to be significantly correlated with age, gender, smoking history, and lung function.
The possibility of an acute exacerbation should be highly suspected if a patient with interstitial pulmonary fibrosis is clinically found to have dyspnea that worsens over a short period of time without evidence of infection, such as a significant increase in sputum volume, or if anti-infective therapy is poorly effective. Interstitial pulmonary fibrosis should be treated in a timely manner to avoid deterioration and the development of cancer, which can threaten the patient's health. Therefore, once patients have similar problems, patients need to consult their doctors in time to ensure their health and avoid serious situations.
Pulmonary fibrosis occurs most often in the age of 40 to 50 years old, and is more common in both men and women. Difficulty in breathing is the most common symptom of pulmonary fibrosis. In patients with mild pulmonary fibrosis, dyspnea often occurs with strenuous activity. When pulmonary fibrosis progresses, dyspnea can also occur at rest. Patients with severe pulmonary fibrosis may have progressive dyspnea. Other symptoms include a dry cough and fatigue. Patients have pestle fingers and cyanosis. The serious consequences of pulmonary fibrosis are structural changes and loss of function of normal lung tissue. There is dyspnea, hypoxia, acidosis and loss of labor.
Interstitial pulmonary fibrosis can also cause emphysema, which can be diagnosed by imaging. If left unchecked, it can cause pneumothorax, which severely impairs the patient's lung function. Patients with interstitial fibrosis are prone to gastroesophageal reflux, which further aggravates pulmonary fibrosis, forming a vicious circle and seriously threatening life and health. The treatment of this disease is difficult and requires treatment of the primary disease, and patients need to adhere to oxygen therapy for a long time. If possible, patients can receive lung transplantation, which is also the most effective way to prolong survival. ?